Torcozia Contraindications

Etoricoxib is contraindicated in patients with a history of hypersensitivity to etoricoxib or any component of the formulation.
Etoricoxib is contraindicated in patients with congestive heart failure (NYHA class II-IV).
Etoricoxib is contraindicated in patients with active peptic ulceration or gastrointestinal (Gl) bleeding.
Etoricoxib is contraindicated in patients with severe hepatic dysfunction (Child-Pugh score >9).
Etoricoxib is contraindicated in patients with severe renal impairment (CrCl <30 ml/min).
Etoricoxib is contraindicated in patients with a history of allergic-type reaction (eg, bronchospasm, acute rhinitis, nasal polyps, angioedema, urticaria) to aspirin or other non-steroidal anti-inflammatory drugs (NSAIDS).
Etoricoxib is contraindicated in pregnancy and lactation.
Etoricoxib is contraindicated in children under 16 years of age.
Etoricoxib is contraindicated in patients with inflammatory bowel disease.
Etoricoxib is contraindicated in patients with established ischemic heart disease, peripheral artery disease and/or cerebrovascular disease (including patients who have recently undergone coronary artery bypass graft surgery or angioplasty).
Etoricoxib is contraindicated in patients with persistent uncontrolled hypertension.